3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gynecologic
5
Breast
3
Thoracic
1
Sarcoma
1
Head & Neck
1
Gastrointestinal
1
Dermatologic
1
Conditions
Rectal Neoplasms
4
Colorectal Neoplasms
4
Colonic Neoplasms
4
Liver Neoplasms
3
Carcinoma, Hepatocellular
3
Precancerous Conditions
2
Pancreatic Neoplasms
2
Esophageal Neoplasms
2
Adenocarcinoma Of Esophagus
2
Small Cell Lung Carcinoma
1
Ovarian Neoplasms
1
Lung Neoplasms
1
Gallbladder Neoplasms
1
Esophageal Squamous Cell Carcinoma
1
Cholangiocarcinoma
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Biliary Tract Neoplasms
1
Adenomatous Polyps
1
Interventions
pembrolizumab
10
Paclitaxel
8
Taxes
6
Nivolumab
4
Cyclophosphamide
4
Cisplatin
4
Carboplatin
4
Polymerase Chain Reaction
3
Irinotecan
3
Interleukin-12 Subunit p35
3
Docetaxel
3
Bevacizumab
3
sargramostim
2
lenvatinib
2
aldesleukin
2
aflibercept
2
Trastuzumab
2
SS1(dsFv)PE38
2
Radiotherapy
2
Psychiatric Rehabilitation
2
Methods
2
Interleukin-12
2
Gene Expression Profiling
2
Gemcitabine
2
Filgrastim
2
Early Intervention, Educational
2
Capecitabine
2
Albumin-Bound Paclitaxel
2
veliparib
1
tocilizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Ovarian Epithelial
×
Mass Spectrometry
×
Gastrointestinal
×
Clear all
NCT00900094
2012-02-07
IRB 2000-294
University of Michigan Rogel Cancer Center
Completed
200 enrolled